Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 1/2 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Stomach Neoplasms 4 Colonic Neoplasms 3 Rectal Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Postoperative Complications 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasms 1 Locally Advanced Colorectal Cancer 1 HER-2 Positive Gastric Cancer 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Colon Cancer Liver Metastasis 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Bile Duct Neoplasms 1 Appendiceal Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

regorafenib 1 raltitrexed 1 Oxaliplatin 1 Ethiodized Oil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Colorectal Cancer Metastatic × Oxaliplatin × Clear all

NCT01959061 2017-03-13

TACE

Nanjing Chia-tai Tianqing Pharmaceutical

Phase 4 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡